4559:TYO
Zeria Pharmaceutical Co Ltd
2 230,00 JPY
arrow_downward
-2,71%(-62,00) 1J
1 juin, 15:30:00 UTC+9 · JPY
search
Tous les symboles
1J
5J
1M
6M
Depuis début année
1AN
5ANS
MAX
| Symbole | Cours | Variation | % variat. |
|---|
insights_autoGénération des principaux insights pour 4559...
Ouverture
2 295 JPY
Élevé
2 295 JPY
Faible
2 200 JPY
Cap. boursière
111,77 Md
Vol. moyen
96,64 k
Volume
122,40 k
Dividende
2,20 %
Dividende trimestriel
12 JPY
Date de détachement du dividende
29 sept. 2025
Ratio cours/bénéfice
11,63
+ haut sur 1 an
2 434 JPY
+ bas sur 1 an
1 878 JPY
BPA
192 JPY
Actions en circulation
50,11 M
Nombre d'employés
2 k
Ouverture
2 295 JPY
Élevé
2 295 JPY
Faible
2 200 JPY
Cap. boursière
111,77 Md
Vol. moyen
96,64 k
Volume
122,40 k
Dividende
2,20 %
Dividende trimestriel
12 JPY
Date de détachement du dividende
29 sept. 2025
Ratio cours/bénéfice
11,63
+ haut sur 1 an
2 434 JPY
+ bas sur 1 an
1 878 JPY
BPA
192 JPY
Actions en circulation
50,11 M
Nombre d'employés
2 k
Articles
Provenant de diverses sources sur le Web
TipRanks
·
il y a 34 minutes
Zeria Pharmaceutical Posts Modest Sales Growth, Projects Profit Rebound and Higher Dividend
Profil
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
À propos de Zeria Pharmaceutical Co Ltd
Les contenus générés par IA peuvent contenir des erreurs. En savoir plus